Pembrolizumab, 25 mg

Pembrolizumab is noted for its consistent composition and reliable behavior, as it belongs to the immunoglobulin class with the molecular formula C85H170N4OS and a molecular weight of 1296.4. This compound is a monoclonal antibody that selectively binds to programmed death-1 (PD-1) proteins, inhibiting their interaction with programmed death ligand-1 (PD-L1) and programmed death ligand-2 (PD-L2), thereby enhancing the immune response against cancer cells. It requires appropriate handling due to its biological nature, including storage at controlled temperatures and disposal Its application primarily focuses on the treatment of various types of cancer, such as melanoma, non-small cell lung cancer, and Hodgkin lymphoma.

• CAS Number: 1374853-91-4
• Molecular Formula: C85H170N4OS
• Exact Mass: 1295.30953723
• Molecular Weight: 1296.4